Multimeric Disintegrin Protein Polymer Fusions That Target Tumor Vasculature

[Image: see text] Recombinant protein therapeutics have increased in number and frequency since the introduction of human insulin, 25 years ago. Presently, proteins and peptides are commonly used in the clinic. However, the incorporation of peptides into clinically approved nanomedicines has been li...

Full description

Saved in:
Bibliographic Details
Main Authors: Janib, Siti M., Gustafson, Joshua A., Minea, Radu O., Swenson, Stephen D., Liu, Shuanglong, Pastuszka, Martha K., Lock, Lye Lin, Cui, Honggang, Markland, Francis S., Conti, Peter S., Li, Zibo, MacKay, J. Andrew
Format: Artigo
Language:Inglês
Published: American Chemical Society 2014
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4098058/
https://ncbi.nlm.nih.gov/pubmed/24871936
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/bm401622y
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items